XOMA Speaks On Diabetes and Obesity Panel At RBC Capital Markets Healthcare Conference Dec 06, 2007 4:35pm EST
XOMA to Present At Lazard Capital Markets Healthcare Conference On November 27 Nov 15, 2007 8:05am EST
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8 Nov 01, 2007 4:35pm EDT
XOMA Initiates Phase 1 European Trial in Diabetes for XOMA 052, a Novel Anti-IL-1 Antibody Designed to Target Diabetes, Rheumatoid Arthritis and Other Inflammatory Diseases Sep 12, 2007 8:05am EDT
